Euromedis Groupe
ALEMG.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.01 | -0.15 |
| FCF Yield | 0.00% | 0.00% | -14.79% | 55.45% |
| EV / EBITDA | -1.00 | -1.43 | -0.02 | 3.43 |
| Quality | ||||
| ROIC | 1.33% | -15.62% | -11.17% | 5.69% |
| Gross Margin | 5.32% | 9.54% | 34.60% | 29.93% |
| Cash Conversion Ratio | – | – | 0.18 | 8.35 |
| Growth | ||||
| Revenue 3-Year CAGR | -12.57% | -30.58% | -34.57% | 13.23% |
| Free Cash Flow Growth | 0.00% | 100.00% | -111.95% | 35.55% |
| Safety | ||||
| Net Debt / EBITDA | 1.33 | 1.99 | 3.10 | -3.72 |
| Interest Coverage | 0.79 | -15.92 | -14.58 | 9.44 |
| Efficiency | ||||
| Inventory Turnover | 2.87 | 3.13 | 2.81 | 6.67 |
| Cash Conversion Cycle | 112.63 | 115.33 | 113.99 | 52.80 |